Track the 큐리오시스 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 큐리오시스 has recorded 23 reports. Market capitalisation: €155.6bn. The latest transaction was disclosed on 7 July 2026 (Other). Among the most active insiders: 신지훈. The full history is openly available.
9
Insider Decl.
n/a
Thresholds
€44,126
7 ops.
Buy Volume
n/a
1 ops.
Sell Volume
24Σ signal
Buys €44,126n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,927 of 28,057 companies
29.5
score / 100
Value
22
Quality
37
FCF yld-5.6%
Earn yld-4.5%
EV/EBITDA·
ROE-41%
Gross mgn48%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
큐리오시스 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.